Reducing risk of adverse cardiovascular and renal outcomes for patients with atrial fibrillation and type 2 diabetes. Harrison SL, Lane DA, Lip GYH. Eur J Heart Fail 2020;22:136-138.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Harrison SL, Lane DA, Lip GYH. Reducing risk of adverse cardiovascular and renal outcomes for patients with atrial fibrillation and type 2 diabetes. Eur J Heart Fail 2020;22:136-138.
PMID: 31820530